8.5 USD
-0.19 (-2.19%)
Last: Feb 9, 2026, 11:18 AM
CCRN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While CCRN has a great health rating, its profitability is only average at the moment. CCRN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year CCRN was profitable.
- CCRN had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
- Of the past 5 years CCRN 4 years had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of -2.91%, CCRN is not doing good in the industry: 60.78% of the companies in the same industry are doing better.
- CCRN has a Return On Equity (-3.84%) which is in line with its industry peers.
- With a Return On Invested Capital value of 0.98%, CCRN perfoms like the industry average, outperforming 42.16% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for CCRN is significantly above the industry average of 9.16%.
- The last Return On Invested Capital (0.98%) for CCRN is well below the 3 year average (15.05%), which needs to be investigated, but indicates that CCRN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROIC | 0.98% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
- CCRN has a Operating Margin (0.56%) which is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of CCRN has declined.
- CCRN has a Gross Margin (20.19%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of CCRN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
- CCRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- CCRN has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
- CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 4.45 indicates that CCRN is not in any danger for bankruptcy at the moment.
- With a decent Altman-Z score value of 4.45, CCRN is doing good in the industry, outperforming 79.41% of the companies in the same industry.
- There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.45 |
ROIC/WACC0.11
WACC8.86%
2.3 Liquidity
- A Current Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
- CCRN has a Current ratio of 3.45. This is amongst the best in the industry. CCRN outperforms 85.29% of its industry peers.
- A Quick Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
- CCRN has a Quick ratio of 3.45. This is amongst the best in the industry. CCRN outperforms 87.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 |
3. Growth
3.1 Past
- The earnings per share for CCRN have decreased strongly by -82.86% in the last year.
- CCRN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.57% yearly.
- Looking at the last year, CCRN shows a very negative growth in Revenue. The Revenue has decreased by -22.14% in the last year.
- CCRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.33% yearly.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
3.2 Future
- Based on estimates for the next years, CCRN will show a very negative growth in Earnings Per Share. The EPS will decrease by -33.46% on average per year.
- Based on estimates for the next years, CCRN will show a decrease in Revenue. The Revenue will decrease by -7.58% on average per year.
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 70.83, which means the current valuation is very expensive for CCRN.
- CCRN's Price/Earnings is on the same level as the industry average.
- CCRN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.93.
- A Price/Forward Earnings ratio of 70.42 indicates a quite expensive valuation of CCRN.
- CCRN's Price/Forward Earnings ratio is in line with the industry average.
- When comparing the Price/Forward Earnings ratio of CCRN to the average of the S&P500 Index (27.77), we can say CCRN is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.83 | ||
| Fwd PE | 70.42 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CCRN is valued a bit cheaper than 78.43% of the companies in the same industry.
- CCRN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CCRN is cheaper than 93.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.1 | ||
| EV/EBITDA | 7.86 |
4.3 Compensation for Growth
- A cheap valuation may be justified as CCRN's earnings are expected to decrease with -33.46% in the coming years.
PEG (NY)N/A
PEG (5Y)2.88
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
5. Dividend
5.1 Amount
- No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:CCRN (2/9/2026, 11:18:03 AM)
8.5
-0.19 (-2.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners96.15%
Inst Owner Change-1.83%
Ins Owners6.14%
Ins Owner Change11.6%
Market Cap278.46M
Revenue(TTM)1.13B
Net Income(TTM)-15.68M
Analysts71.43
Price Target11.68 (37.41%)
Short Float %4.08%
Short Ratio1.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.09%
Min EPS beat(2)-118.38%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-49.67%
Min EPS beat(4)-118.38%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)-23.71%
EPS beat(12)7
Avg EPS beat(12)-12.92%
EPS beat(16)11
Avg EPS beat(16)-6.6%
Revenue beat(2)0
Avg Revenue beat(2)-8.46%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-7.46%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)-36.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.83 | ||
| Fwd PE | 70.42 | ||
| P/S | 0.25 | ||
| P/FCF | 6.1 | ||
| P/OCF | 5.13 | ||
| P/B | 0.68 | ||
| P/tB | 1.17 | ||
| EV/EBITDA | 7.86 |
EPS(TTM)0.12
EY1.41%
EPS(NY)0.12
Fwd EY1.42%
FCF(TTM)1.39
FCFY16.4%
OCF(TTM)1.66
OCFY19.48%
SpS34.42
BVpS12.46
TBVpS7.25
PEG (NY)N/A
PEG (5Y)2.88
Graham Number5.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROCE | 1.39% | ||
| ROIC | 0.98% | ||
| ROICexc | 1.26% | ||
| ROICexgc | 2.43% | ||
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% | ||
| FCFM | 4.05% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 49.56% | ||
| Cap/Sales | 0.76% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 229.81% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 | ||
| Altman-Z | 4.45 |
F-Score5
WACC8.86%
ROIC/WACC0.11
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
EBIT growth 1Y-52.34%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year494.68%
EBIT Next 3Y80.04%
EBIT Next 5YN/A
FCF growth 1Y-79.94%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-77.47%
OCF growth 3YN/A
OCF growth 5Y85.29%
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCRN.
What is the valuation status for CCRN stock?
ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.
Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for CCRN stock?
The Earnings per Share (EPS) of CROSS COUNTRY HEALTHCARE INC (CCRN) is expected to decline by -76.58% in the next year.